i2E & Plains Ventures Surpasses $100M Milestone in Total Investments
Innovation 2 Enterprise
NOVEMBER 21, 2024
Notable investment successes include: Crescendo Bioscience , an early i2E investment, was acquired for $270 million in 2014. The $100 million milestone was made possible through collaboration with numerous partners and stakeholders. Selexys Pharmaceuticals was acquired by Novartis for $665 million in October 2016. million in 2001.
Let's personalize your content